Phosphofructokinase deficiency: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
 
(2 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{Infobox_Disease |
#REDIRECT [[Glycogen storage disease type VII]]
  Name          = {{PAGENAME}} |
  Image          = |
  Caption        = |
  DiseasesDB    = 5314 |
  ICD10          = {{ICD10|E|74|0|e|70}} |
  ICD9          = {{ICD9|271.0}} |
  ICDO          = |
  OMIM          = 232800 |
  MedlinePlus    = |
  MeshID        = D006014 |
}}
{{SI}}
{{CMG}}
 
'''''Synonyms and Keywords:''''' Glycogenosis type 7 or Tarui disease or Glycogen storage disease type 7.
 
==Overview==
Phosphofructokinase deficiency, also known as '''Glycogen storage disease type VII''' or '''Tarui's disease'''<ref>{{WhoNamedIt|synd|3022}}</ref>, is a [[metabolic disorder]] with [[autosomal recessive]] inheritance, in which deficiency of the M subunit of the [[phosphofructokinase]] [[enzyme]] impairs the ability of cells such as [[erythrocytes]] and [[Skeletal muscle|rhabdomyocyte]]s to use [[carbohydrate]]s (such as [[glucose]]) for energy. It may affects humans as well as other mammals (especially dogs).  In humans it is the least common type of [[glycogen storage disease]].
 
==Presentation==
The disease presents with exercise-induced [[muscle cramps]] and [[weakness]] (sometimes [[rhabdomyolysis]]), as well as with [[hemolytic anemia]] causing dark urine a few hours later.
 
==References==
{{reflist|2}}
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
 
[[Category:Disease]]
[[Category:Endocrinology]]
[[Category:Inborn errors of metabolism]]

Latest revision as of 14:31, 3 January 2018